4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-24-036349
Chief Scientific Officer sold 1,010 shares at $16.02 ($16,177)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lorrain Daniel S. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-25 | Sale : show line 1 in the form 10b5-1 | −1,010 | $16.02 | $16,177 | 168,562 | D |
| Open-market sales · 1,010 sh · avg $16.02 · $16,177 | ||||||
Loading xslF345X05/rdgdoc.xml…